Cipla Completes Phase-3 Clinical Study Of A Billion-Dollar Asthma Generic
An employee holds capsules for a photograph inside a coating unit at a pharmaceutical plant in Goa, India. Photographer: Dhiraj Singh/Bloomberg

Cipla Completes Phase-3 Clinical Study Of A Billion-Dollar Asthma Generic

Cipla Ltd. said it successfully completed the clinical endpoint study evaluating the safety and efficacy of a generic of Glaxo SmithKline Plc.’s respiratory drug Advair Diskus.The Phase-3 clinical ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.